Nance–Horan syndrome
Nance–Horan syndrome (NHS) is a rare genetic disorder characterized by congenital cataracts, dental anomalies, and distinctive facial features. It is an X-linked recessive condition, meaning it primarily affects males, while females are typically carriers and may exhibit milder symptoms.
Clinical Features[edit | edit source]
Individuals with Nance–Horan syndrome often present with:
- Congenital cataracts: Clouding of the lens of the eye present at birth, leading to visual impairment.
- Microcornea: Abnormally small cornea.
- Dental anomalies: Including screwdriver-shaped incisors, supernumerary teeth, and delayed dental eruption.
- Facial dysmorphism: Features such as a long face, large anteverted ears, and a broad nasal bridge.
- Intellectual disability: Varying degrees of cognitive impairment are observed in some individuals.
Genetics[edit | edit source]
Nance–Horan syndrome is caused by mutations in the NHS gene located on the X chromosome. The NHS gene is responsible for encoding a protein involved in the development of the eyes, teeth, and brain. Due to its X-linked recessive inheritance pattern, males with a single mutated copy of the gene exhibit the full spectrum of symptoms, while females with one mutated copy are typically carriers and may show milder manifestations.
Diagnosis[edit | edit source]
Diagnosis of Nance–Horan syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the NHS gene. Prenatal diagnosis is possible if there is a known family history of the disorder.
Management[edit | edit source]
Management of Nance–Horan syndrome is symptomatic and supportive, including:
- Surgical intervention for cataracts to improve vision.
- Regular dental care to address dental anomalies.
- Educational support and therapies for individuals with intellectual disabilities.
Epidemiology[edit | edit source]
Nance–Horan syndrome is a rare disorder, with its exact prevalence unknown. It has been reported in various populations worldwide.
History[edit | edit source]
The syndrome was first described by Walter E. Nance and Mary Horan in 1974, who identified the characteristic features and inheritance pattern of the disorder.
See Also[edit | edit source]
Related Pages[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD